Innate Pharma announces the appointment of two new members to its Board of Directors: Arvind Sood, Executive Vice President, President U.S. Operations, and Sonia Quaratino, Executive Vice President, Chief Medical Officer.

Yannis Morel, currently Executive Vice President, Product Strategy and Business Development, and member of the Board, is promoted to Executive Vice President, Chief Operating Officer, adding research and early development to his responsibilities.

As previously announced, Hervé Brailly has been acting Chairman of the Board since January 1, 2024, pending a permanent successor to this position. Co-founder of Innate Pharma, he was formerly Chairman of the Supervisory Board.

Copyright (c) 2024 CercleFinance.com. All rights reserved.